BioRestorative Therapies (FRA:9OF) Cyclically Adjusted Book per Share: €-1,543.95 (As of Mar. 2026)


FRA:9OF BioRestorative Therapies Inc FRA:9OF
51 GF Score
Price €0.31
GF Value €1.26
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is BioRestorative Therapies Cyclically Adjusted Book per Share?

BioRestorative Therapies FRA:9OF -3.68% 51 Cyclically Adjusted Book per Share is €-1,543.95 as of Mar. 2026. GuruFocus rates FRA:9OF with a GF Score™ of 51/100 and a GF Value™ of €1.26 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BioRestorative Therapies's adjusted book value per share for the three months ended in Mar. 2026 was €0.103. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €-1,543.95 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 10.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BioRestorative Therapies was 10.60% per year. The lowest was 7.80% per year. And the median was 8.20% per year.

As of today (2026-07-01), BioRestorative Therapies's current stock price is €0.314. BioRestorative Therapies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €-1,543.95. BioRestorative Therapies's Cyclically Adjusted PB Ratio of today is .


BioRestorative Therapies  (FRA:9OF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BioRestorative Therapies Cyclically Adjusted Book per Share Related Terms


BioRestorative Therapies Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for BioRestorative Therapies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioRestorative Therapies Cyclically Adjusted Book per Share Chart

BioRestorative Therapies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,404.05 -2,451.85 -2,325.89 -2,237.26 -1,455.81

BioRestorative Therapies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,034.91 -1,767.01 -1,722.21 -1,455.81 -1,543.95

FRA:9OF vs CVKD, JSPR, APRE: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, BioRestorative Therapies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioRestorative Therapies Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioRestorative Therapies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioRestorative Therapies's Cyclically Adjusted PB Ratio falls into.


FRA:9OF
51GF Score
BioRestorative Therapies Inc FRA:9OF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioRestorative Therapies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioRestorative Therapies's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.103/330.2130*330.2130
=0.103

Current CPI (Mar. 2026) = 330.2130.

BioRestorative Therapies Quarterly Data

Book Value per Share CPI Adj_Book
201606 -3,564.000 241.018 -4,882.951
201609 -3,984.000 241.428 -5,449.114
201612 -4,740.000 241.432 -6,483.025
201703 -4,415.000 243.801 -5,979.838
201706 -5,086.000 244.955 -6,856.212
201709 -5,613.000 246.819 -7,509.493
201712 -2,888.500 246.524 -3,869.077
201803 -3,118.500 249.554 -4,126.439
201806 -4,223.500 251.989 -5,534.585
201809 -3,830.000 252.439 -5,009.986
201812 -2,531.667 251.233 -3,327.546
201903 -1,693.250 254.202 -2,199.562
201906 -1,582.800 256.143 -2,040.505
201909 -1,881.000 256.759 -2,419.119
201912 -605.158 256.974 -777.631
202003 -39.774 258.115 -50.884
202006 -32.140 257.797 -41.168
202009 -32.115 260.280 -40.744
202012 -1.528 260.474 -1.937
202103 -2.850 264.877 -3.553
202106 -3.777 271.696 -4.590
202109 -4.756 274.310 -5.725
202112 5.426 278.802 6.427
202203 5.036 287.504 5.784
202206 4.821 296.311 5.373
202209 4.706 296.808 5.236
202212 2.637 296.797 2.934
202303 3.339 301.836 3.653
202306 2.871 305.109 3.107
202309 2.572 307.789 2.759
202312 1.946 306.746 2.095
202403 1.969 312.332 2.082
202406 1.448 314.175 1.522
202409 1.299 315.301 1.360
202412 1.175 315.605 1.229
202503 0.756 319.799 0.781
202506 0.525 322.561 0.537
202509 0.234 324.800 0.238
202512 0.033 324.054 0.034
202603 0.103 330.213 0.103

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €-1,543.95 mean?
BioRestorative Therapies (FRA:9OF) has a Cyclically Adjusted Book per Share of €-1,543.95 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BioRestorative Therapies and its competitors.
Is BioRestorative Therapies' Cyclically Adjusted Book per Share too high?
BioRestorative Therapies' current Cyclically Adjusted Book per Share is €-1,543.95. Overall, BioRestorative Therapies has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioRestorative Therapies' Cyclically Adjusted Book per Share compare to CVKD and JSPR?
BioRestorative Therapies' Cyclically Adjusted Book per Share of €-1,543.95 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BioRestorative Therapies and its competitors. BioRestorative Therapies's current Cyclically Adjusted Book per Share is €-1,543.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioRestorative Therapies stock overvalued right now?
Based on GuruFocus' analysis, BioRestorative Therapies (FRA:9OF) is currently considered Possible Value Trap. The stock's GF Value™ is €1.26, compared to a current price of €0.31 — trading 75.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is €-1,543.95. BioRestorative Therapies' overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For BioRestorative Therapies (FRA:9OF), the current Cyclically Adjusted Book per Share is €-1,543.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioRestorative Therapies (FRA:9OF) Overvalued in 2026?

Based on GuruFocus' analysis, BioRestorative Therapies stock appears to be undervalued. The current stock price of €0.31 is trading 75.1% below its estimated GF Value™ of €1.26. GuruFocus considers BioRestorative Therapies to be Possible Value Trap.

Key valuation signals for FRA:9OF:

  • Cyclically Adjusted Book per Share: €-1,543.95
  • GF Value™: €1.26 vs. price of €0.31 (75.1% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the FRA:9OF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioRestorative Therapies Business Description

Other Exchanges BRTX:USA
Address 40 Marcus Drive, Suite One, Melville, NY, USA, 11747
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
51GF Score

Get the complete analysis for FRA:9OF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.31
Price
€1.26
GF Value